KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 12,720
0.00 (0.00%)
At close: Feb 13, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 138.73 billion as of February 13, 2026. Its market cap has decreased by -18.62% in one year.
Market Cap
138.73B
Enterprise Value
143.54B
Revenue
90.11B
Ranking
n/a
PE Ratio
796.61
Stock Price
12,720.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 138.73B, a decrease of -24.51%. That is a compound annual growth rate of -4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 138.73B | -2.15% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GREEN CROSS WellBeing | 165.38B |
| High Tech Pharm | 160.99B |
| Kyung Dong Pharmaceutical | 153.57B |
| DongKoo Bio & Pharma | 146.84B |
| BL Pharmtech | 144.87B |
| PHARMARESEARCH BIO | 144.86B |
| OPTUS Pharmaceutical | 141.17B |
| Samik Pharmaceutical Company LTD. | 135.74B |